{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:10:11Z","timestamp":1790964611983,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DE 614\/16-1"],"award-info":[{"award-number":["DE 614\/16-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ctro.2022.100567","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T02:22:54Z","timestamp":1671416574000},"page":"100567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk"],"prefix":"10.1016","volume":"39","author":[{"given":"Philipp","family":"Hoegen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-1999","authenticated-orcid":false,"given":"Efthimios","family":"Katsigiannopulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Buchele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-884X","authenticated-orcid":false,"given":"Sebastian","family":"Regnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Weykamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5584-6909","authenticated-orcid":false,"given":"Jonas","family":"Ristau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1445-1940","authenticated-orcid":false,"given":"Jakob","family":"Liermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7087-9581","authenticated-orcid":false,"given":"Eva","family":"Meixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Katharina","family":"Renkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-928X","authenticated-orcid":false,"given":"Carolin","family":"Rippke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3139-3444","authenticated-orcid":false,"given":"Sebastian","family":"Kl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","article-title":"Metastases in carcinoma. Analysis of 1000 autopsied cases","volume":"3","author":"Abrams","year":"1950","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ctro.2022.100567_b0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00000441-195322650-00007","article-title":"Metastatic carcinoma of the adrenal","volume":"226","author":"Bullock","year":"1953","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2020.01.017","article-title":"Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients","volume":"107","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","article-title":"Metastatic tumours of the adrenal glands: A 30-year experience in a teaching hospital","volume":"56","author":"Lam","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.ctro.2022.100567_b0025","first-page":"2760","volume":"73","author":"Newton","year":"2014","journal-title":"Markov chain Monte Carlo Mathematical Model"},{"key":"10.1016\/j.ctro.2022.100567_b0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00423-011-0889-1","article-title":"Surgical management of adrenal metastases. Langenbeck\u2019s","volume":"397","author":"Sancho","year":"2012","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0035","first-page":"98","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"LancetOncol"},{"issue":"10185","key":"10.1016\/j.ctro.2022.100567_b0040","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2022.100567_b0045","unstructured":"Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ, et al. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non\u2013Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. Journal of Clinical Oncology [Internet]. 2019 May 8;JCO.19.00201. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.19.00201."},{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5603\/RPOR.a2021.0104","article-title":"Stereotactic radiotherapy for adrenal oligometastases","volume":"27","author":"Borghesi","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ctro.2022.100567_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-1480-0","article-title":"Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients","author":"K\u00f6nig","year":"2020","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2022.100567_b0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ijc.33546","article-title":"Stereotactic or conformal radiotherapy for adrenal metastases: patient characteristics and outcomes in a multicenter analysis","volume":"149","author":"Buergy","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctro.2022.100567_b0065","doi-asserted-by":"crossref","unstructured":"Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol [Internet]. 2014 Apr 1;15(4):387\u201395. Available from: https:\/\/doi.org\/10.1016\/S1470-2045(14)70061-0.","DOI":"10.1016\/S1470-2045(14)70221-9"},{"key":"10.1016\/j.ctro.2022.100567_b0070","doi-asserted-by":"crossref","unstructured":"Gaebe K, Li AY, Park A, Parmar A, Lok BH, Sahgal A, et al. Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis. Lancet Oncol [Internet]. 2022 Jul 1;23(7):931\u20139. Available from: https:\/\/doi.org\/10.1016\/S1470-2045(22)00271-6.","DOI":"10.1016\/S1470-2045(22)00271-6"},{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2008.06.1939","article-title":"Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation","volume":"74","author":"Guckenberger","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2022.100567_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2011.04.034","article-title":"Which is the optimal biologically effective dose of stereotactic body radiotherapy for stage i non-small-cell lung cancer? A meta-analysis","volume":"81","author":"Zhang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.100567_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4191-2","article-title":"The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases","author":"Andratschke","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2022.100567_b0090","article-title":"Local control after stereotactic body radiation therapy for liver tumors","author":"Ohri","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.100567_b0095","doi-asserted-by":"crossref","unstructured":"van Vliet C, Dickhoff C, Bahce I, Engelsman AF, Hashemi SMS, Haasbeek CJA, et al. Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period. Radiotherapy and Oncology [Internet]. 2022;170:165\u20138. Available from: https:\/\/doi.org\/10.1016\/j.radonc.2022.02.023.","DOI":"10.1016\/j.radonc.2022.02.023"},{"key":"10.1016\/j.ctro.2022.100567_b0100","doi-asserted-by":"crossref","unstructured":"Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, et al. The transformation of radiation oncology using real-time magnetic resonance guidance: A review. Eur J Cancer [Internet]. 2019;122:42\u201352. Available from: https:\/\/doi.org\/10.1016\/j.ejca.2019.07.021.","DOI":"10.1016\/j.ejca.2019.07.021"},{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/1754-9485.12968","article-title":"Magnetic resonance-guided radiation therapy: a review","volume":"64","author":"Chin","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ctro.2022.100567_b0110","doi-asserted-by":"crossref","unstructured":"Corradini S, Alongi F, Andratschke N, Belka C, Boldrini L, Cellini F, et al. MR-guidance in clinical reality: Current treatment challenges and future perspectives. Vol. 14, Radiation Oncology. BioMed Central Ltd.; 2019.","DOI":"10.1186\/s13014-019-1308-y"},{"key":"10.1016\/j.ctro.2022.100567_b0115","series-title":"Magnetic-resonance-guided radiotherapy: The beginning of a new era in radiation oncology?","author":"Hoegen","year":"2020"},{"issue":"2","key":"10.1016\/j.ctro.2022.100567_b0120","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2018.06.002","article-title":"Role of daily plan adaptation in MR-guided stereotactic ablative radiation therapy for adrenal metastases","volume":"102","author":"Palacios","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.100567_b0125","doi-asserted-by":"crossref","unstructured":"Rodriguez LL, Kotecha R, Tom MC, Chuong MD, Contreras JA, Romaguera T, et al. CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy. Radiotherapy and Oncology [Internet]. 2022;166:101\u20139. Available from: https:\/\/doi.org\/10.1016\/j.radonc.2021.11.024.","DOI":"10.1016\/j.radonc.2021.11.024"},{"key":"10.1016\/j.ctro.2022.100567_b0130","doi-asserted-by":"crossref","unstructured":"Chen H, Schneiders FL, Bruynzeel AME, Lagerwaard FJ, van S\u00f6rnsen de Koste JR, Cobussen P, et al. Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy: NTCP advantages of adaptive MR-guided adrenal SABR. Radiotherapy and Oncology [Internet]. 2021;163:14\u201320. Available from: https:\/\/doi.org\/10.1016\/j.radonc.2021.07.026.","DOI":"10.1016\/j.radonc.2021.07.026"},{"issue":"17","key":"10.1016\/j.ctro.2022.100567_b0135","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/cncr.25997","article-title":"Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2022.100567_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2016.09.005","article-title":"Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity","volume":"7","author":"Chance","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2022.100567_b0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ijc.34017","article-title":"Stereotactic body radiotherapy of adrenal metastases\u2014a dose-finding study","volume":"151","author":"Buergy","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctro.2022.100567_b0150","first-page":"417","volume":"Vol. 196","author":"Guckenberger","year":"2020","journal-title":"Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery"},{"key":"10.1016\/j.ctro.2022.100567_b0155","doi-asserted-by":"crossref","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. Journal of Clinical Oncology [Internet]. 1995 Jan 1;13(1):8\u201310. Available from: https:\/\/doi.org\/10.1200\/JCO.1995.13.1.8.","DOI":"10.1200\/JCO.1995.13.1.8"},{"key":"10.1016\/j.ctro.2022.100567_b0160","doi-asserted-by":"crossref","unstructured":"Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol [Internet]. 2011;8(6):378\u201382. Available from: https:\/\/doi.org\/10.1038\/nrclinonc.2011.44.","DOI":"10.1038\/nrclinonc.2011.44"},{"key":"10.1016\/j.ctro.2022.100567_b0165","doi-asserted-by":"crossref","unstructured":"Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol [Internet]. 2020;21(1):e18\u201328. Available from: http:\/\/dx.doi.org\/10.1016\/S1470-2045(19)30718-1.","DOI":"10.1016\/S1470-2045(19)30718-1"},{"key":"10.1016\/j.ctro.2022.100567_b0170","first-page":"98","article-title":"Technical design and concept of a 0.35 T MR-Linac","volume":"18","author":"Kl\u00fcter","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2022.100567_b0175","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00066-020-01578-z","article-title":"First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany","volume":"196","author":"Kl\u00fcter","year":"2020","journal-title":"Strahlentherapie und Onkologie"},{"issue":"1","key":"10.1016\/j.ctro.2022.100567_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2022.100567_b0185","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin Oncol"},{"issue":"17","key":"10.1016\/j.ctro.2022.100567_b0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.phro.2020.12.005","article-title":"A practical implementation of risk management for the clinical introduction of online adaptive Magnetic Resonance-guided radiotherapy","volume":"1","author":"Kl\u00fcter","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ctro.2022.100567_b0195","doi-asserted-by":"crossref","unstructured":"Witt JS, Rosenberg SA, Bassetti MF. MRI-guided adaptive radiotherapy for liver tumours: visualising the future. Lancet Oncol [Internet]. 2020;21(2):e74\u201382. Available from: http:\/\/dx.doi.org\/10.1016\/S1470-2045(20)30034-6.","DOI":"10.1016\/S1470-2045(20)30034-6"},{"issue":"3","key":"10.1016\/j.ctro.2022.100567_b0200","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijrobp.2020.03.005","article-title":"Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 individual treatments","volume":"107","author":"Klement","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.100567_b0205","doi-asserted-by":"crossref","unstructured":"Hoegen P, Lang C, Akbaba S, H\u00e4ring P, Splinter M, Miltner A, et al. Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung. Front Oncol [Internet]. 2020 Dec 9 [cited 2020 Dec 29];10. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33363005\/.","DOI":"10.3389\/fonc.2020.564857"},{"key":"10.1016\/j.ctro.2022.100567_b0210","doi-asserted-by":"crossref","unstructured":"Cusumano D, Dhont J, Boldrini L, Chiloiro G, Teodoli S, Massaccesi M, et al. Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR. Radiotherapy and Oncology [Internet]. 2018;129(3):456\u201362. Available from: https:\/\/doi.org\/10.1016\/j.radonc.2018.07.025.","DOI":"10.1016\/j.radonc.2018.07.025"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:12:05Z","timestamp":1762503125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630822001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":42,"alternative-id":["S2405630822001252"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2022.100567","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2022.100567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100567"}}